An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers.
Latest Information Update: 14 Dec 2021
At a glance
- Drugs Elsulfavirine (Primary)
- Indications COVID 2019 infections; HIV infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Viriom
- 19 Apr 2017 New trial record